Exact Mass: 466.1006

Exact Mass Matches: 466.1006

Found 29 metabolites which its exact mass value is equals to given mass value 466.1006, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-Adenylylanthranilate

N-Adenylylanthranilate

C17H19N6O8P (466.1002)


   

benfotiamine

N-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-N-(4-hydroxy-2-mercapto-1-methyl-1-butenyl)formamide S-benzoic acid O-phosphoric acid

C19H23N4O6PS (466.1076)


A - Alimentary tract and metabolism > A11 - Vitamins > A11D - Vitamin b1, plain and in combination with vitamin b6 and b12 > A11DA - Vitamin b1, plain D064449 - Sequestering Agents > D002614 - Chelating Agents D007155 - Immunologic Factors

   

HOPEAFURAN

HOPEAFURAN

C28H18O7 (466.1052)


   

CHEMBL608844

CHEMBL608844

C17H18N6O8S (466.0907)


   

mongolicin B

mongolicin B

C28H18O7 (466.1052)


   

9,8-[1-Hydroxy-2-(4-hydroxyphenyl)ethylene]-13-oxa-13H-indeno[1,2-l]phenanthrene-3,5,7,11-tetraol

9,8-[1-Hydroxy-2-(4-hydroxyphenyl)ethylene]-13-oxa-13H-indeno[1,2-l]phenanthrene-3,5,7,11-tetraol

C28H18O7 (466.1052)


   

benfotiamine

S-Benzoylthiamine O-monophosphate

C19H23N4O6PS (466.1076)


A - Alimentary tract and metabolism > A11 - Vitamins > A11D - Vitamin b1, plain and in combination with vitamin b6 and b12 > A11DA - Vitamin b1, plain D064449 - Sequestering Agents > D002614 - Chelating Agents D007155 - Immunologic Factors

   

MMV687700

MMV687700

C17H18N6O8S (466.0907)


   

Cys Asp Asp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carboxypropanamido]-3-carboxypropanamido]butanedioic acid

C15H22N4O11S (466.1006)


   

Asp Cys Asp Asp

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-sulfanylpropanamido]-3-carboxypropanamido]butanedioic acid

C15H22N4O11S (466.1006)


   

Asp Asp Cys Asp

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-3-sulfanylpropanamido]butanedioic acid

C15H22N4O11S (466.1006)


   

Asp Asp Asp Cys

(3S)-3-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C15H22N4O11S (466.1006)


   

Ziprasidone Hydrochloride Monohydrate

Ziprasidone Hydrochloride Monohydrate

C21H24Cl2N4O2S (466.0997)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Ziprasidone (CP-88059) hydrochloride monohydrate is an orally active combined 5-HT and dopamine receptor antagonist[1]. Ziprasidone hydrochloride monohydrate has affinities for Rat D2 (Ki=4.8 nM), 5-HT2A (Ki=0.42 nM) and 5-HT1A (Ki=3.4 nM)[1].

   

Varlitinib

Varlitinib

C22H19ClN6O2S (466.0979)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

   

2-Chloro-5-{[(3,4,5-triethoxybenzoyl)carbamothioyl]amino}benzoic acid

2-Chloro-5-{[(3,4,5-triethoxybenzoyl)carbamothioyl]amino}benzoic acid

C21H23ClN2O6S (466.0965)


   

1(2H)-Isoquinolinone, 5,8-dichloro-2-((1,2-dihydro-4-methoxy-6-methyl-2-oxo-3-pyridinyl)methyl)-3,4-dihydro-7-((R)-methoxy-3-oxetanylmethyl)-

1(2H)-Isoquinolinone, 5,8-dichloro-2-((1,2-dihydro-4-methoxy-6-methyl-2-oxo-3-pyridinyl)methyl)-3,4-dihydro-7-((R)-methoxy-3-oxetanylmethyl)-

C22H24Cl2N2O5 (466.1062)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C156804 - EZH2 Inhibitor

   

Salicyl-AMS

Salicyl-AMS

C17H18N6O8S (466.0907)


   

3-(1,3-Benzothiazol-2-YL)-2-(1,4-dioxo-1,2,3,4-tetrahydrophthalazin-6-YL)-5-[(E)-2-phenylvinyl]-3H-tetraazol-2-ium

3-(1,3-Benzothiazol-2-YL)-2-(1,4-dioxo-1,2,3,4-tetrahydrophthalazin-6-YL)-5-[(E)-2-phenylvinyl]-3H-tetraazol-2-ium

C24H16N7O2S+ (466.1086)


   

N-adenylylanthranilic acid

N-adenylylanthranilic acid

C17H19N6O8P (466.1002)


   

5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride hydrate

5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride hydrate

C21H24Cl2N4O2S (466.0997)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants

   

5-O-[(S)-[(2-Aminobenzoyl)oxy](Hydroxy)phosphoryl]adenosine

5-O-[(S)-[(2-Aminobenzoyl)oxy](Hydroxy)phosphoryl]adenosine

C17H19N6O8P (466.1002)


   

N-[(6-chloro-1H-benzimidazol-2-yl)methyl]-2-(4-morpholinyl)-9-(3-thiophenyl)-6-purinamine

N-[(6-chloro-1H-benzimidazol-2-yl)methyl]-2-(4-morpholinyl)-9-(3-thiophenyl)-6-purinamine

C21H19ClN8OS (466.1091)


   

4-[4-[(5Z)-5-[(Z)-2-Methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoylamino]benzoic acid

4-[4-[(5Z)-5-[(Z)-2-Methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoylamino]benzoic acid

C24H22N2O4S2 (466.1021)


   

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 4-aminobenzoate

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 4-aminobenzoate

C17H19N6O8P (466.1002)


   

4,6,12-trihydroxy-8,16-bis(4-hydroxyphenyl)-15-oxatetracyclo[8.6.1.0²,⁷.0¹⁴,¹⁷]heptadeca-1(16),2,4,6,10(17),11,13-heptaen-9-one

4,6,12-trihydroxy-8,16-bis(4-hydroxyphenyl)-15-oxatetracyclo[8.6.1.0²,⁷.0¹⁴,¹⁷]heptadeca-1(16),2,4,6,10(17),11,13-heptaen-9-one

C28H18O7 (466.1052)


   

(8s)-4,6,12-trihydroxy-8,16-bis(4-hydroxyphenyl)-15-oxatetracyclo[8.6.1.0²,⁷.0¹⁴,¹⁷]heptadeca-1(16),2,4,6,10(17),11,13-heptaen-9-one

(8s)-4,6,12-trihydroxy-8,16-bis(4-hydroxyphenyl)-15-oxatetracyclo[8.6.1.0²,⁷.0¹⁴,¹⁷]heptadeca-1(16),2,4,6,10(17),11,13-heptaen-9-one

C28H18O7 (466.1052)


   

(1s)-17-(6-hydroxy-1-benzofuran-2-yl)-11-methyl-2,20-dioxapentacyclo[11.7.1.0³,⁸.0⁹,²¹.0¹⁴,¹⁹]henicosa-3,5,7,9(21),10,12,14,16,18-nonaene-1,5,15-triol

(1s)-17-(6-hydroxy-1-benzofuran-2-yl)-11-methyl-2,20-dioxapentacyclo[11.7.1.0³,⁸.0⁹,²¹.0¹⁴,¹⁹]henicosa-3,5,7,9(21),10,12,14,16,18-nonaene-1,5,15-triol

C28H18O7 (466.1052)


   

17-(6-hydroxy-1-benzofuran-2-yl)-11-methyl-2,20-dioxapentacyclo[11.7.1.0³,⁸.0⁹,²¹.0¹⁴,¹⁹]henicosa-3,5,7,9(21),10,12,14,16,18-nonaene-1,5,15-triol

17-(6-hydroxy-1-benzofuran-2-yl)-11-methyl-2,20-dioxapentacyclo[11.7.1.0³,⁸.0⁹,²¹.0¹⁴,¹⁹]henicosa-3,5,7,9(21),10,12,14,16,18-nonaene-1,5,15-triol

C28H18O7 (466.1052)


   

(14s,15s)-14-(4-hydroxyphenyl)-23-oxahexacyclo[11.8.1.1²,²⁰.0³,⁸.0⁹,²².0¹⁶,²¹]tricosa-1,3(8),4,6,9(22),10,12,16,18,20-decaene-6,10,12,15,18-pentol

(14s,15s)-14-(4-hydroxyphenyl)-23-oxahexacyclo[11.8.1.1²,²⁰.0³,⁸.0⁹,²².0¹⁶,²¹]tricosa-1,3(8),4,6,9(22),10,12,16,18,20-decaene-6,10,12,15,18-pentol

C28H18O7 (466.1052)